Neurescue’s intelligent balloon catheter receives FDA approval for emergency haemorrhage control
Neurescue, a Copenhagen, Denmark-based medical device company developing cardiovascular solutions, has received U.S. FDA clearance to market the company’s NEURESCUE device for temporary occlusion of large vessels, including patients requiring emergency control of haemorrhage.